FDA.reportPublic FDA data

Application 090610

Type
ANDA
Sponsor
IPCA LABS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CHLOROQUINE PHOSPHATECHLOROQUINE PHOSPHATETABLET;ORAL250MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63304-460Chloroquine phosphateChloroquine phosphateRanbaxy Pharmaceuticals Inc.ANDACurrent
76385-142Chloroquine phosphateChloroquine phosphateBayshore Pharmaceuticals LLCANDACurrent
76385-142Chloroquine phosphateChloroquine phosphateBayshore Pharmaceuticals LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
62502SUPPL2020-04-08
62501SUPPL2020-04-08
62500SUPPL2020-04-08
62499SUPPL2020-04-08